News and Trends 17 Mar 2023
Beyond Biotech podcast 38: Hello Tomorrow Global Summit
The Hello Tomorrow Global Summit took place in Paris last week (March 8-10), and we feature interviews with four of…
Gene editing
- Latest Posts
In Depth 10 Mar 2023
Can CRISPR bring back extinct animals?
The concept of de-extinction has been around for many years. Once considered a fanciful idea, recent advancements in technology -…
News and Trends 23 Feb 2023
Moderna and Life Edit Therapeutics look to speed up gene editing therapies
Moderna, Inc., a biotechnology company working on messenger RNA (mRNA) therapeutics and vaccines, and Life Edit Therapeutics Inc., an ElevateBio…
News and Trends 3 Feb 2023
AI boosts genome editing
Researchers at the University of Zurich have developed a new tool that uses artificial intelligence to predict the efficacy of…
ADVERTISEMENT
News and Trends 26 Jan 2023
Milestone for gene-edited therapy for sickle cell disease
Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics have announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application…
News and Trends 11 Nov 2022
PACT Pharma reports data from CRISPR cancer study
PACT Pharma, Inc. has reported data from the first clinical study using CRISPR gene editing technology to substitute a gene…
In Depth 3 Nov 2022
What’s on the horizon for gene editing-based therapies?
Gene editing has come far in the past decade. However, the field is still finding its feet regarding challenges such…
In Depth 20 Oct 2022
Opportunities and challenges for cell and gene therapy investments
Companies in the cell and gene therapy space are struggling to raise investments amid adverse market conditions. However, this could…
Interview 17 Oct 2022
CRISPR gene editing: a key tool for counteracting climate change
Monika Paulė, CEO and co-founder of the Lithuanian CRISPR developer Caszyme, explains how gene editing technology could fight climate change…
News and Trends 17 Oct 2022
The challenges of translating CRISPR to the clinic
CRISPR-Cas9 is revolutionizing all facets of drug discovery, allowing for both a deeper understanding of disease processes, and for the…
ADVERTISEMENT
More News! 29 Sep 2022
Removing binding sites for an oncogene can slow cancer cell growth, researchers say
Cancer cell growth could be slowed down by removing binding sites for an oncogene, researchers from the University of Helsinki…
News and Trends 28 Sep 2022
Scribe Therapeutics enters into agreement with Sanofi for use of its CRISPR technologies
Scribe Therapeutics has entered into an agreement with Sanofi which will allow Sanofi use of its CRISPR genome editing technologies.…
News and Trends 7 Sep 2022
Lesaffre acquires genome editing company Recombia Biosciences
Lesaffre has acquired Recombia Biosciences, a biotech company based in the San Francisco Bay Area founded in 2019 based on…
News and Trends 24 Aug 2022
Gene therapies for lung cancer identified by international team of scientists
Gene therapies for lung cancer can be found by CRISPR genome editing technology, an international team of scientists have discovered.…
Sponsored by ProteoGenix
16 Aug 2022Optimizing bioproduction using transient expression systems
During drug development, biologics often fail to transition from the preclinical to the clinical stage, resulting in huge losses in…
Interview 10 Aug 2022
How the UK precision breeding bill could unshackle gene editing
The U.K. is considering lowering restrictions on gene-edited crops. PacBio’s Neil Ward explains how the changes could impact the gene…
ADVERTISEMENT
News and Trends 8 Aug 2022
Epigenic Therapeutics raises $20M for gene editing technology
Epigenic Therapeutics Co., Ltd., a Chinese biotech gene editing company, has secured $20 million in Series Angel and Pre-A funding. …
News and Trends 3 Aug 2022
Poseida Therapeutics and Roche to focus on therapies for hematologic malignancies
Poseida Therapeutics, Inc. has entered into a broad strategic collaboration and license agreement with Roche, focused on developing allogeneic CAR-T…
In Depth 26 Jul 2022
How DNA sequencing can safeguard against biodiversity loss
Preserving Earth’s biodiversity is crucial as we rely on healthy ecosystems for many services, from clean air and water to…
News and Trends 25 Jul 2022
Replay launches with $55M to reprogram biology by writing and delivering big DNA
Replay, a genome writing company reprogramming biology by writing and delivering big DNA, has launched with $55 million in seed…